More than 40 years ago, Apollonia Kotero met Prince when she auditioned to play his love interest in 1984’s Purple Rain. She landed the part, and he named the character in the semi-autobiographical musical film after her. Now the actress, whose full name is Patricia Apollonia Kotero, is suing the late singer’s estate, Paisley Park […]

Ozempic and other GLP-1 weight-loss medications are seeing explosive growth in popularity, but they’re also facing billions of dollars in lawsuits and growing concerns about long-term safety. Human Performance Coach and Transformation Specialist Coach Chris is in the house to break down what these medications really do,

Patients' vision loss, which is rare according to a new study, is also the subject of multiple lawsuits, including two filed by Long Islanders.

In the past year or couple of years, you’ve likely heard a lot about Ozempic, most likely in the context of weight loss. Not for nothing — a lot of people turned to this diabetes medicine with the hopes that it would help them lose weight — and it did.

Tennis star Serena Williams' candor about her GLP-1 use may help dispel the pesky health inaccuracy that weight loss is a simple matter of exercise.

A host of women have complained that they are experiencing 'Ozempic vulva' after taking weight loss drugs to shed the pounds.

New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an increased risk of rare eye conditions.

Know about Ozempic Vulva, a lesser-known side effect of popular weight-loss drugs, and what women need to know for safe and informed weight management.

People with obesity who take weight loss and diabetes drugs like Ozempic and Mounjaro could face a lower risk of cancer compared to those with obesity who do not. Looking at 14 cancers, of which 13 were associated with obesity,

From tiny plates to mini martinis, this is how menus are being shaped by a weight-loss era - FOOD FOCUS: From luxe mini menus to teeny tiny tasting formats, restaurants are rewriting the rules in response to their customers on weight-loss drugs like Ozempic and Mounjaro.